Arena Pharmaceuticals Inc

ARNACIK 0001080709 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed Mar 10, 2022. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback

Full filing:tone 0.0006

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

YoY shift: Unscored

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Arena Pharmaceuticals Inc

Name	Roles	Filings
Knobil Katharine	Director	1
Neil Garry Arthur	Director	1
Nova Tina Susan	Director	1
Ouzren Nawal	Director	1
Schoch Steven J	Director	1

Showing 11-15 of 15

Per pagePrevPage 3 of 3

All filings

21 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Mar 11, 2022	Manion Douglas J. EVP Research & Development	JOther	15,000	-	-
Mar 11, 2022	Ouzren Nawal Director	JOther	890	-	-
Mar 11, 2022	Dallas Jayson Donald Alexander Director	JOther	4,085	-	-
Mar 11, 2022	Schoch Steven J Director	JOther	4,600	-	-
Mar 11, 2022	Neil Garry Arthur Director	JOther	8,150	-	-

Showing 6-10 of 21

Per pagePrevPage 2 of 5Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value